We are live on ! Find out more
IMNN icon

Imunon

40 hedge funds and large institutions have $16.4M invested in Imunon in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,854% more capital inflows, than outflows

Capital inflows: $15.7M | Capital outflows: $532K

750% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 2

60% more funds holding

Funds holding: 25 → 40 (+15)

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

7.28% more ownership

Funds ownership: 8.55% → 15.83% (+7.3%)

13% less call options, than puts

Call options by funds: $502K | Put options by funds: $575K

Holders
40
Holders Change
+15
Holders Change %
+60%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
9
Reduced
6
Closed
2
Calls
$502​K
Puts
$575​K
Net Calls
-⁠$73​K
Net Calls Change
-⁠$83​K

IMNN Hedge Fund Activity: Q1 2021 in Review

40 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2021, worth a combined $16.4M — up 620% from $2.28M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMNN positions and 2 closed out — a net gain of 15 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $6M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $211K.

  • 40 institutional investors held Imunon (IMNN) as of Q1 2021, up from 25 in Q4 2020.
  • Funds reported $16.4M of Imunon stock for Q1 2021, up 620% quarter-over-quarter.
  • 17 funds opened new Imunon positions in Q1 2021 and 2 closed out, a net change of +15 holders.
  • The largest Imunon buyer in Q1 2021 was Altium Capital Management, an estimated $6M added.
  • The largest Imunon seller in Q1 2021 was Qube Research & Technologies (QRT), an estimated $211K sold.

Based on aggregated 13F filings for Q1 2021.